TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:17 pm Unchanged | 2025-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 66,879 3.500% | 0 (Unchanged) | Filing |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 66,879 3.500% | -100,000 (-59.92%) | Filing |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 166,879 8.700% | 166,879 (New Position) | Filing |